<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02391519</url>
  </required_header>
  <id_info>
    <org_study_id>14-2178</org_study_id>
    <nct_id>NCT02391519</nct_id>
  </id_info>
  <brief_title>Effects of High Altitude on AMPK Activation</brief_title>
  <official_title>Effects of High Altitude on 5' Adenosine Monophosphate-activated Protein Kinase (AMPK) Activation and Peroxisome Proliferator-activated Receptor Gamma (PPARÎ³) Regulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pregnancy elicits adaptive changes in uteroplacental blood flow, which are altered at high
      altitude and may contribute to the observed 3-fold increase in intrauterine growth
      restriction (IUGR) and preeclampsia (PreE). The investigators propose to collect myometrial,
      cord blood, and placental tissue samples from women at high altitude (Summit County) and low
      altitude (Denver) in Colorado in order to determine if residence at altitude during pregnancy
      changes the vasoreactivity of myometrial arteries (MA). If altered MA vasoreactivity is
      found, further studies may be able to link these changes to the increased rates of PreE and
      IUGR at altitude and contribute to the understanding of these two disorders.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Investigators will determine if residence at altitude during pregnancy changes the
      vasoreactivity of myometrial arteries. This will be novel information regarding pregnancy at
      altitude and of significance not just for women and families in Colorado, but also at
      high-altitude locations throughout the world. If altered MA vasoreactivity is found, further
      studies may be able to link these changes to the increased rates of PreE and IUGR at altitude
      and contribute to the understanding of these two disorders.

      The Investigators will also determine whether the chronic hypoxia of high altitude alters DNA
      methylation patterns and expression of key genes involved in metabolic homeostasis in
      maternal, placental and fetal cells and, in turn, the relationship of these changes to fetal
      growth and maternal well-being.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in Myometrial artery dimensions</measure>
    <time_frame>Up to 1 year</time_frame>
    <description>Myometrial artery dimensions as quantified by immunohistochemistry or other staining techniques, and results of studies of isolated myometrial artery studies in which vasoconstrictor and vasodilator responses to pharmacological agonists are measured using absolute values and the percent maximal contraction to potassium chloride.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">84</enrollment>
  <condition>Pregnancy</condition>
  <condition>IUGR</condition>
  <condition>Preeclampsia</condition>
  <arm_group>
    <arm_group_label>High Altitude (3000 m)</arm_group_label>
    <description>Collection of myometrial, cord blood, and placental tissue samples from women at high altitude (Summit County) and low altitude (Denver) in Colorado in order to determine if residence at altitude during pregnancy changes the vasoreactivity of myometrial arteries (MA).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low Altitude (1600 m)</arm_group_label>
    <description>Collection of myometrial, cord blood, and placental tissue samples from women at high altitude (Summit County) and low altitude (Denver) in Colorado in order to determine if residence at altitude during pregnancy changes the vasoreactivity of myometrial arteries (MA).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Collection of myometrial, cord blood, and placental tissue samples</intervention_name>
    <description>We propose to collect myometrial, cord blood, and placental tissue samples from women at high altitude (Summit County) and low altitude (Denver) in Colorado in order to determine if residence at altitude during pregnancy changes the vasoreactivity of myometrial arteries (MA).</description>
    <arm_group_label>High Altitude (3000 m)</arm_group_label>
    <arm_group_label>Low Altitude (1600 m)</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Myometrial tissue, Cord Blood, Placental Tissue.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Women scheduled for cesarean delivery at University of Colorado Hospital (Denver, 1600 m)
        and St. Anthony's Summit Medical Center (Summit County, 3000 m) will be identified. In
        order to avoid any possible confounding effects of labor or prematurity, only women with
        elective cesarean deliveries will be approached for enrollment (cesarean delivery at a
        prescheduled time without any labor, typically at 39 weeks gestation).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women scheduled for cesarean delivery at University of Colorado Hospital (Denver, 1600
             m) and St. Anthony's Summit Medical Center (Summit County, 3000 m)

          -  Cesarean delivery at a prescheduled time without any labor, typically at 39 weeks
             gestation

        Exclusion Criteria:

          -  Women will be excluded if there are co-existing medical diagnoses that are known to
             affect vascular parameters (i.e., diabetes mellitus, gestational diabetes, any
             hypertensive disorder of pregnancy, or a current smoker).

          -  Women with multiple gestations and preterm deliveries will also be excluded.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lorna Moore, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lorna Moore, PhD</last_name>
    <phone>303-724-7474</phone>
    <email>lorna.moore@ucdenver.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Chanel Mansfield, BBA</last_name>
    <phone>303-724-6501</phone>
    <email>chanel.mansfield@ucdenver.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Colorado Denver Anschutz Medical Campus</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chanel Mansfield, BBA</last_name>
      <phone>303-724-6501</phone>
      <email>chanel.mansfield@ucdenver.edu</email>
    </contact>
    <investigator>
      <last_name>Lorna Moore, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anna Euser, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Colleen Julian, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Osol G, Moore LG. Maternal uterine vascular remodeling during pregnancy. Microcirculation. 2014 Jan;21(1):38-47. doi: 10.1111/micc.12080.</citation>
    <PMID>23941526</PMID>
  </reference>
  <reference>
    <citation>Zamudio S, Palmer SK, Droma T, Stamm E, Coffin C, Moore LG. Effect of altitude on uterine artery blood flow during normal pregnancy. J Appl Physiol (1985). 1995 Jul;79(1):7-14.</citation>
    <PMID>7559250</PMID>
  </reference>
  <reference>
    <citation>Krampl ER, Espinoza-Dorado J, Lees CC, Moscoso G, Bland JM, Campbell S. Maternal uterine artery Doppler studies at high altitude and sea level. Ultrasound Obstet Gynecol. 2001 Dec;18(6):578-82.</citation>
    <PMID>11844192</PMID>
  </reference>
  <reference>
    <citation>Julian CG, Galan HL, Wilson MJ, Desilva W, Cioffi-Ragan D, Schwartz J, Moore LG. Lower uterine artery blood flow and higher endothelin relative to nitric oxide metabolite levels are associated with reductions in birth weight at high altitude. Am J Physiol Regul Integr Comp Physiol. 2008 Sep;295(3):R906-15. doi: 10.1152/ajpregu.00164.2008. Epub 2008 Jun 25.</citation>
    <PMID>18579652</PMID>
  </reference>
  <reference>
    <citation>Palmer SK, Moore LG, Young D, Cregger B, Berman JC, Zamudio S. Altered blood pressure course during normal pregnancy and increased preeclampsia at high altitude (3100 meters) in Colorado. Am J Obstet Gynecol. 1999 May;180(5):1161-8.</citation>
    <PMID>10329872</PMID>
  </reference>
  <reference>
    <citation>Moore LG, Hershey DW, Jahnigen D, Bowes W Jr. The incidence of pregnancy-induced hypertension is increased among Colorado residents at high altitude. Am J Obstet Gynecol. 1982 Oct 15;144(4):423-9.</citation>
    <PMID>7124861</PMID>
  </reference>
  <reference>
    <citation>Jensen GM, Moore LG. The effect of high altitude and other risk factors on birthweight: independent or interactive effects? Am J Public Health. 1997 Jun;87(6):1003-7.</citation>
    <PMID>9224184</PMID>
  </reference>
  <reference>
    <citation>Keyes LE, Armaza JF, Niermeyer S, Vargas E, Young DA, Moore LG. Intrauterine growth restriction, preeclampsia, and intrauterine mortality at high altitude in Bolivia. Pediatr Res. 2003 Jul;54(1):20-5. Epub 2003 Apr 16.</citation>
    <PMID>12700368</PMID>
  </reference>
  <reference>
    <citation>White MM, McCullough RE, Dyckes R, Robertson AD, Moore LG. Chronic hypoxia, pregnancy, and endothelium-mediated relaxation in guinea pig uterine and thoracic arteries. Am J Physiol Heart Circ Physiol. 2000 Jun;278(6):H2069-75.</citation>
    <PMID>10843906</PMID>
  </reference>
  <reference>
    <citation>Xiao D, Longo LD, Zhang L. Role of KATP and L-type Ca2+ channel activities in regulation of ovine uterine vascular contractility: effect of pregnancy and chronic hypoxia. Am J Obstet Gynecol. 2010 Dec;203(6):596.e6-12. doi: 10.1016/j.ajog.2010.07.038.</citation>
    <PMID>20817142</PMID>
  </reference>
  <reference>
    <citation>Luksha L, Luksha N, Kublickas M, Nisell H, Kublickiene K. Diverse mechanisms of endothelium-derived hyperpolarizing factor-mediated dilatation in small myometrial arteries in normal human pregnancy and preeclampsia. Biol Reprod. 2010 Nov;83(5):728-35. doi: 10.1095/biolreprod.110.084426. Epub 2010 Jul 7.</citation>
    <PMID>20610807</PMID>
  </reference>
  <reference>
    <citation>Cockell AP, Poston L. Flow-mediated vasodilatation is enhanced in normal pregnancy but reduced in preeclampsia. Hypertension. 1997 Aug;30(2 Pt 1):247-51.</citation>
    <PMID>9260988</PMID>
  </reference>
  <reference>
    <citation>Sladek SM, Magness RR, Conrad KP. Nitric oxide and pregnancy. Am J Physiol. 1997 Feb;272(2 Pt 2):R441-63. Review.</citation>
    <PMID>9124465</PMID>
  </reference>
  <reference>
    <citation>Clapp JF 3rd, Capeless E. Cardiovascular function before, during, and after the first and subsequent pregnancies. Am J Cardiol. 1997 Dec 1;80(11):1469-73.</citation>
    <PMID>9399724</PMID>
  </reference>
  <reference>
    <citation>Palmer SK, Zamudio S, Coffin C, Parker S, Stamm E, Moore LG. Quantitative estimation of human uterine artery blood flow and pelvic blood flow redistribution in pregnancy. Obstet Gynecol. 1992 Dec;80(6):1000-6. Review.</citation>
    <PMID>1448242</PMID>
  </reference>
  <reference>
    <citation>Kametas NA, McAuliffe F, Krampl E, Chambers J, Nicolaides KH. Maternal cardiac function during pregnancy at high altitude. BJOG. 2004 Oct;111(10):1051-8.</citation>
    <PMID>15383106</PMID>
  </reference>
  <reference>
    <citation>Zamudio S, Palmer SK, Dahms TE, Berman JC, Young DA, Moore LG. Alterations in uteroplacental blood flow precede hypertension in preeclampsia at high altitude. J Appl Physiol (1985). 1995 Jul;79(1):15-22.</citation>
    <PMID>7559213</PMID>
  </reference>
  <reference>
    <citation>Mateev S, Sillau AH, Mouser R, McCullough RE, White MM, Young DA, Moore LG. Chronic hypoxia opposes pregnancy-induced increase in uterine artery vasodilator response to flow. Am J Physiol Heart Circ Physiol. 2003 Mar;284(3):H820-9. Epub 2002 Nov 14.</citation>
    <PMID>12433660</PMID>
  </reference>
  <reference>
    <citation>Wang X, Proud CG. The mTOR pathway in the control of protein synthesis. Physiology (Bethesda). 2006 Oct;21:362-9. Review.</citation>
    <PMID>16990457</PMID>
  </reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 3, 2015</study_first_submitted>
  <study_first_submitted_qc>March 12, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 18, 2015</study_first_posted>
  <last_update_submitted>August 29, 2017</last_update_submitted>
  <last_update_submitted_qc>August 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pregnancy</keyword>
  <keyword>High altitude</keyword>
  <keyword>vasoreactivity</keyword>
  <keyword>myometrial arteries</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pre-Eclampsia</mesh_term>
    <mesh_term>Altitude Sickness</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

